Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 13, 2021 and accepted by EDGAR at Aug 13, 2021, 16:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2021-04-01 to 2021-06-30$879.8kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$1.1mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-04-01 to 2021-06-30$2.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2021-01-01 to 2021-06-30$8.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-04-01 to 2021-06-30−$3.4mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$10.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-04-01 to 2021-06-30$4.8kus-gaap:InterestExpense
Interest expense6 months2021-01-01 to 2021-06-30$4.8kus-gaap:InterestExpense
Net income3 months2021-04-01 to 2021-06-30−$908.3kus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30−$4.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30−$0.22us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2021-01-01 to 2021-06-30−$5.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2021-06-30$20.6mus-gaap:Cash
Current assetsAt period end2021-06-30$21.5mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$23.7mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$1.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$4.9mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$18.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-21-019738. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.